Astrom Research International (ARI) is a CRO and specialised consultancy focusing exclusively on the Chinese market. We turn to Western companies in the Life Science sector intending to conduct clinical research or set up operations in China.
The strength of ARI lies in the combination of vast experience within clinical trials management, an extensive local contact network and cultural insight. All parts necessary to perform clinical research in China.
We operate through a network of high quality university hospitals in all major Chinese cities and work cooperatively with key regulatory authorities on both provincial and national level.
ARI has concluded agreements with multiple major hospitals in China in specified areas of cooperation. These agreements cover areas such as International Clinical M/C Trials in Chinese hospitals, GCP Training of Investigators and site Monitors, and Organisation of Conferences and Seminars in EU, US and China.